CWA Asset Management Group LLC acquired a new stake in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 952 shares of the medical instruments supplier's stock, valued at approximately $1,428,000.
A number of other large investors also recently bought and sold shares of the stock. PDS Planning Inc purchased a new stake in shares of Mettler-Toledo International in the 3rd quarter valued at approximately $211,000. QRG Capital Management Inc. increased its holdings in Mettler-Toledo International by 9.1% in the 3rd quarter. QRG Capital Management Inc. now owns 382 shares of the medical instruments supplier's stock valued at $573,000 after purchasing an additional 32 shares during the last quarter. Asset Management One Co. Ltd. raised its position in Mettler-Toledo International by 4.6% in the third quarter. Asset Management One Co. Ltd. now owns 18,545 shares of the medical instruments supplier's stock valued at $27,812,000 after purchasing an additional 813 shares during the period. National Pension Service lifted its stake in Mettler-Toledo International by 8.0% during the third quarter. National Pension Service now owns 34,039 shares of the medical instruments supplier's stock worth $51,048,000 after purchasing an additional 2,521 shares in the last quarter. Finally, Donaldson Capital Management LLC boosted its position in shares of Mettler-Toledo International by 2.2% during the third quarter. Donaldson Capital Management LLC now owns 3,182 shares of the medical instruments supplier's stock worth $4,772,000 after buying an additional 68 shares during the period. Institutional investors and hedge funds own 95.07% of the company's stock.
Insider Buying and Selling at Mettler-Toledo International
In other news, insider Christian Magloth sold 1,000 shares of the stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the transaction, the insider now owns 734 shares in the company, valued at approximately $1,044,459.98. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.94% of the stock is owned by insiders.
Mettler-Toledo International Trading Down 7.2 %
NYSE:MTD traded down $101.49 during mid-day trading on Friday, hitting $1,310.03. The stock had a trading volume of 254,186 shares, compared to its average volume of 119,785. Mettler-Toledo International Inc. has a twelve month low of $953.28 and a twelve month high of $1,546.93. The stock has a 50-day simple moving average of $1,398.01 and a two-hundred day simple moving average of $1,401.35. The company has a market capitalization of $27.80 billion, a PE ratio of 36.05, a PEG ratio of 4.09 and a beta of 1.16.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating analysts' consensus estimates of $10.00 by $0.21. The business had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a net margin of 20.95% and a negative return on equity of 575.61%. Sell-side analysts predict that Mettler-Toledo International Inc. will post 40.34 EPS for the current fiscal year.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on MTD shares. Wells Fargo & Company started coverage on Mettler-Toledo International in a research note on Tuesday, August 27th. They set an "equal weight" rating and a $1,400.00 target price on the stock. JPMorgan Chase & Co. raised their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a "neutral" rating in a research note on Monday, August 5th. Stifel Nicolaus upped their target price on shares of Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the stock a "buy" rating in a research note on Monday, August 5th. Finally, Evercore ISI increased their target price on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an "in-line" rating in a report on Tuesday, October 1st. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $1,363.75.
Read Our Latest Stock Analysis on Mettler-Toledo International
Mettler-Toledo International Profile
(
Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
See Also
Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.